Sell Sesa Goa, Maruti; buy Kilitch Drugs

Kilitch Drugs (Buy above Rs 83.90, target of Rs 87)

Kilitch Drugs, late Friday evening announced selling its manufacturing and research unit in Paonta Sahib, Himachal Pradesh, to an American company, Akorn. The unit is sold as a 'slump sale' for Rs 200 crore, which adjusted for its outstanding debt works out to Rs 120 per share. The stock can move to at least Rs 100, based on this news.

Sesa Goa (Sell below Rs 204, target of Rs 195)

 Sell Sesa Goa, Maruti; buy Kilitch Drugs

Newspapers have said that Sesa Goa has been found guilty of under invoicing its exports to the tune of Rs 1002 crore. Reuters

Newspapers have said that Sesa Goa has been found guilty of under invoicing its exports to the tune of Rs 1002 crore and over invoicing coking coal worth Rs 14.6 crore. The company has been in the midst of scams off late, this accusation will just add to the selling pressure on the counter.

Maruti (Sell below Rs 1115, target of Rs 1075)

Maruti's workers have resumed their strike in Manesar and have resorted to violence by damaging property in its factory premises. With labour unrest showing no sign of slowing down, Maruti, which is already losing market share is likely to impacted by analyst downgrades.

FIRSTPOST DISCLAIMER: Firstpost brings you information and opinions on shares, funds and other investment options based on broker reports and private equity research. Investors are, however, warned that they should NOT take any buy or sell decision based on the views expressed in our posts or what market movements. Investors should consult their own financial and share advisors before taking purchase or sale decisions. Firstpost does not take any responsibility for any losses incurred by investors who take their cues from our posts and chat sessions.

Updated Date: Dec 20, 2014 15:07:34 IST